0001140361-20-027869.txt : 20201209
0001140361-20-027869.hdr.sgml : 20201209
20201209161704
ACCESSION NUMBER: 0001140361-20-027869
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201208
FILED AS OF DATE: 20201209
DATE AS OF CHANGE: 20201209
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WOOD LAUREN
CENTRAL INDEX KEY: 0001769757
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37568
FILM NUMBER: 201378033
MAIL ADDRESS:
STREET 1: 300 CONNELL DRIVE
STREET 2: SUITE 4000
CITY: BERKELEY HEIGHTS
STATE: NJ
ZIP: 07922
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PDS Biotechnology Corp
CENTRAL INDEX KEY: 0001472091
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 264231384
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 25B VREELAND ROAD
CITY: FLORHAM PARK
STATE: NJ
ZIP: 07932
BUSINESS PHONE: 800-208-3343
MAIL ADDRESS:
STREET 1: 25B VREELAND ROAD
CITY: FLORHAM PARK
STATE: NJ
ZIP: 07932
FORMER COMPANY:
FORMER CONFORMED NAME: Edge Therapeutics, Inc.
DATE OF NAME CHANGE: 20090911
4
1
form4.xml
FORM 4
X0306
4
2020-12-08
0001472091
PDS Biotechnology Corp
PDSB
0001769757
WOOD LAUREN
C/O PDS BIOTECHNOLOGY CORPORATION
25B VREELAND ROAD
FLORHAM PARK
NJ
07932
true
Chief Medical Officer
Stock Option (Right to Buy)
2.43
2020-12-08
4
A
0
210500
0
A
2030-12-08
Common Stock
210500
210500
D
The option was granted on December 8, 2020, subject to stockholder approval of the Issuer's Second Amended and Restated 2014 Equity Incentive Plan under Nasdaq Marketplace Rule 5635(c). The option is not exercisable until stockholder approval has been obtained. Contingent upon stockholder approval, one-quarter of the shares subject to the option shall vest on December 8, 2021, and the remainder shall vest in equal monthly installments thereafter until fully vested on December 8, 2024. In the event stockholder approval is not obtained pursuant to the terms of grant, then the Reporting Person shall surrender the option to the Company for cancellation.
/s/ Hillary Yegen, attorney-in-fact
2020-12-09